Intuitive Surgical stock is trading -19.25% below its average target price of $368.32 after dropping -2.1% during today's afternoon session. Analysts are giving the large-cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $315.0 to $400.0 per share.
The stock has a very low short interest at 0.9%, and a short ratio of 1.84. The company's insiders own 0.51% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 87.6% of Intuitive Surgical's shares being owned by this investor type.
Institutions Invested in Intuitive Surgical
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2023-06-30 | Vanguard Group Inc | 8% | 29,671,911 | $8,824,426,150 |
2023-06-30 | Blackrock Inc. | 8% | 29,579,371 | $8,796,904,754 |
2023-06-30 | Price (T.Rowe) Associates Inc | 5% | 19,022,095 | $5,657,170,936 |
2023-06-30 | State Street Corporation | 4% | 14,810,625 | $4,404,679,784 |
2023-06-30 | FMR, LLC | 2% | 8,194,650 | $2,437,088,859 |
2023-06-30 | JP Morgan Chase & Company | 2% | 8,018,676 | $2,384,754,193 |
2023-06-30 | Capital World Investors | 2% | 7,510,586 | $2,233,648,230 |
2023-06-30 | Bank Of New York Mellon Corporation | 2% | 7,119,920 | $2,117,464,164 |
2023-06-30 | Alliancebernstein L.P. | 2% | 6,957,880 | $2,069,273,469 |
2023-06-30 | Geode Capital Management, LLC | 2% | 6,612,636 | $1,966,597,906 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Intuitive Surgical.